Singapore markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.6600+0.1100 (+4.31%)
At close: 3:29PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,307
859.781
2,942
6,645
3,186
Selling general and administrative
6,358
1,270
3,015
7,544
1,699
Total operating expenses
10,749
2,246
6,159
14,315
4,971
Operating income or loss
-10,749
-2,246
-6,159
-14,315
-4,971
Interest expense
1,463
1,882
1,464
142.173
52.806
Total other income/expenses net
-3,128
116.761
369.698
-377.224
25.411
Income before tax
-15,325
-4,011
-7,241
-14,833
-4,998
Income from continuing operations
-15,325
-4,011
-7,241
-14,833
-4,998
Net income
-15,165
-3,997
-7,176
-13,232
-4,318
Net income available to common shareholders
-15,165
-3,997
-7,176
-13,232
-4,318
Basic EPS
-
-0.31
-0.56
-1.03
-0.34
Diluted EPS
-
-0.31
-0.56
-1.03
-0.34
Basic average shares
-
12,865
12,865
12,865
12,865
Diluted average shares
-
12,865
12,865
12,865
12,865
EBITDA
-
-2,012
-5,575
-14,565
-4,860